Mauro Bernardi Selected Research

Thrombosis (Thrombus)

2/2018	Metronomic capecitabine as second-line treatment for hepatocellular carcinoma after sorafenib discontinuation.
9/2004	Combined mechanical and pharmacologic thrombolysis for portal vein thrombosis in liver-graft recipients and in candidates for liver transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mauro Bernardi Research Topics

Disease

62	Fibrosis (Cirrhosis) 08/2023 - 03/2002
26	Ascites 01/2023 - 10/2002
19	Liver Cirrhosis (Hepatic Cirrhosis) 08/2023 - 07/2005
19	Infections 01/2022 - 07/2002
15	Hepatocellular Carcinoma (Hepatoma) 02/2018 - 01/2002
13	End Stage Liver Disease 11/2020 - 10/2002
13	Alcoholism (Alcohol Abuse) 10/2016 - 09/2005
11	Hepatorenal Syndrome 10/2020 - 04/2008
10	Liver Diseases (Liver Disease) 01/2020 - 10/2002
10	Neoplasms (Cancer) 02/2018 - 09/2005
8	Bacterial Infections (Bacterial Infection) 01/2021 - 10/2010
7	Inflammation (Inflammations) 01/2021 - 10/2008
7	Peritonitis 01/2020 - 11/2013
7	Portal Hypertension 01/2020 - 04/2003
6	Acute-On-Chronic Liver Failure 10/2019 - 11/2015
6	Chronic Hepatitis C 03/2014 - 05/2004
5	Hemorrhage 10/2020 - 04/2007
5	Liver Neoplasms (Liver Cancer) 01/2018 - 09/2005
5	Chronic Hepatitis B 01/2017 - 04/2011
5	Liver Failure 12/2015 - 05/2010
4	Hyponatremia 01/2023 - 04/2012
4	Hepatitis C 04/2015 - 09/2009
4	Hepatitis B 05/2010 - 10/2002
3	Hepatic Encephalopathy 10/2019 - 12/2014
3	Fatty Liver 11/2018 - 07/2004
3	Renal Insufficiency (Renal Failure) 01/2016 - 03/2011
3	Reperfusion Injury 05/2009 - 04/2005
2	Necrosis 01/2020 - 10/2006
2	Sepsis (Septicemia) 10/2019 - 07/2014
2	Body Weight (Weight, Body) 01/2019 - 08/2015
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2018 - 01/2007
2	Hypovolemia 11/2018 - 12/2014
2	Thrombosis (Thrombus) 02/2018 - 09/2004
2	Reinfection 07/2014 - 04/2008
2	Hepatitis 01/2013 - 04/2011
2	Shock 02/2012 - 08/2011
2	Alcoholic Liver Diseases (Alcoholic Liver Disease) 11/2011 - 01/2010
2	Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis) 07/2010 - 01/2010
2	Chronic Hepatitis (Chronic Active Hepatitis) 04/2010 - 10/2002
1	Mitochondrial Diseases (Mitochondrial Disease) 08/2023

Drug/Important Bio-Agent (IBA)

30	AlbuminsIBA 08/2023 - 03/2011
15	SodiumIBA 11/2020 - 06/2002
11	Human Serum Albumin FDA LinkGeneric 08/2023 - 12/2012
10	Antiviral Agents (Antivirals)IBA 04/2015 - 07/2002
8	Anti-Bacterial Agents (Antibiotics)IBA 10/2021 - 06/2014
8	CytokinesIBA 01/2019 - 05/2004
8	DiureticsIBA 11/2018 - 07/2003
7	InterferonsIBA 04/2015 - 09/2004
7	Ribavirin (Virazole)FDA LinkGeneric 03/2014 - 09/2004
6	Serum AlbuminIBA 01/2021 - 10/2002
6	Sodium Oxybate (gamma Hydroxybutyrate)FDA Link 04/2016 - 09/2005
5	TerlipressinIBA 10/2020 - 03/2011
5	Proteins (Proteins, Gene)FDA Link 01/2017 - 10/2007
5	EndocannabinoidsIBA 03/2012 - 02/2009
5	alpha-Fetoproteins (alpha-Fetoprotein)IBA 08/2010 - 09/2005
4	C-Reactive ProteinIBA 11/2020 - 06/2013
4	gamma-Aminobutyric Acid (GABA)IBA 01/2019 - 01/2010
4	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 11/2018 - 08/2010
4	Biomarkers (Surrogate Marker)IBA 10/2017 - 06/2012
4	BilirubinIBA 01/2017 - 10/2002
4	Protein Isoforms (Isoforms)IBA 10/2016 - 12/2014
4	Vasoconstrictor AgentsIBA 01/2016 - 04/2008
4	RNA (Ribonucleic Acid)IBA 03/2014 - 03/2008
4	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2013 - 03/2009
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2021 - 12/2018
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 08/2015
3	Sorafenib (BAY 43-9006)FDA Link 02/2018 - 03/2015
3	Hepatitis B e AntigensIBA 01/2017 - 01/2013
3	4-hydroxybutyric acidIBA 03/2016 - 08/2007
3	Peptides (Polypeptides)IBA 01/2013 - 04/2008
3	Spironolactone (Aldactone)FDA LinkGeneric 08/2010 - 07/2003
2	AntioxidantsIBA 01/2020 - 12/2014
2	ChemokinesIBA 01/2019 - 01/2017
2	CreatinineIBA 01/2019 - 03/2011
2	ReninIBA 01/2019 - 08/2010
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2019 - 01/2017
2	SolutionsIBA 01/2019 - 08/2005
2	Ethanol (Ethyl Alcohol)IBA 11/2018 - 01/2017
2	Arginine Vasopressin (Argipressin)IBA 11/2018 - 12/2014
2	Furosemide (Lasix)FDA LinkGeneric 01/2018 - 08/2010
2	NucleotidesIBA 01/2017 - 03/2016
2	Midodrine (Midon)FDA LinkGeneric 08/2015 - 03/2011
2	Octreotide (Sandostatin)FDA LinkGeneric 08/2015 - 03/2011
2	Colloids (Colloid)IBA 12/2013 - 07/2003
2	AntigensIBA 03/2013 - 04/2008
2	Interferon-alpha (Interferon Alfa)IBA 02/2013 - 05/2004
2	RimonabantIBA 03/2012 - 07/2009
2	Carbon Tetrachloride (Tetrachloromethane)IBA 03/2012 - 07/2009
2	CannabinoidsIBA 03/2012 - 07/2009
2	satavaptanIBA 01/2012 - 08/2010
2	DNA (Deoxyribonucleic Acid)IBA 08/2010 - 04/2008
2	Lamivudine (Epivir)FDA Link 01/2009 - 10/2002
1	galacturonic acidIBA 08/2023
1	hexanoylcarnitineIBA 08/2023

Therapy/Procedure

26	Therapeutics 10/2021 - 10/2002
24	Liver Transplantation 01/2022 - 03/2002
3	Surgical Instruments (Clip) 03/2010 - 09/2005
2	Length of Stay 11/2020 - 10/2019
2	Transplantation 12/2007 - 07/2004
2	Transjugular Intrahepatic Portasystemic Shunt 07/2003 - 04/2003